Scorecard › Baskets › Pharma › who's right about pharma

Pharma vs PPH

4 of 5 pharma headliners beat PPH over the last year (4 of 5 over six months, 3 of 5 over three). Every line is measured against the benchmark itself, so the zero line is PPH.

Weekly closes through 2026-10-29. The zero line is the benchmark: a name "beats" when its total return over the window is higher than PPH's. Rebuilt every morning.

Beat PPH over 6M
4 of 5
Beat PPH over 1Y
4 of 5
Beat PPH over 3Y
3 of 5

Total return

Name6Mvs bench1Yvs bench3Yvs benchSince
PPH benchmark +16.7%0+24.1%0+52.2%0—
LLY +44.3% +27.6 +48.1% +24.0 +141.0% +88.8 2021-10
JNJ +24.1% +7.4 +47.3% +23.2 +81.5% +29.3 2021-10
PFE +16.0% -0.7 +22.0% -2.1 -4.7% -56.9 2021-10
MRK +31.8% +15.1 +70.2% +46.1 +42.0% -10.2 2021-10
ABBV +43.5% +26.8 +32.0% +7.9 +104.5% +52.3 2021-10

A name whose history starts inside a window is measured from its first bar, not the window start — the "Since" column says where. Its "vs bench" (marked *) compares it with PPH over that same shorter span.

Headliners

LLYJNJPFEMRKABBV

Benchmarks available on the dashboard: PPH, XLV.

The wider pharma universe

The dashboard's Sleepers view screens these 23 lesser-covered names for the ones beating PPH on a trailing basis, with liquidity, price and coverage floors so nothing untradeable or already crowded gets through.

BMYAZNNVOGSKSNYNVSTAKTEVAVTRSZTSOGNJAZZPRGOAMPHCTLTRDYHROWELANPCRXANIPCOLLSUPNEYPT

Other baskets

SemiconductorsSemi EquipmentCybersecurityBig BanksRegional BanksBrokers & ExchangesOil & Gas MajorsOil ServicesNat Gas & LNGPower & GridNuclearSolar & CleanBiotechMedical DevicesRobotics & Physical AIQuantumSportsbooks & iGamingSpaceCrypto

Interactive chart with 6M–5Y windows, relative / indexed / drawdown modes and the sleeper screen: Baskets tab.

How calls are checked

Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →

Get the daily brief

Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.